CS
ACER

Credit Suisse’s Acer Therapeutics Inc ACER Stock Holding History

Credit Suisse’s Portfolio ACER Stock Details ACER Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q2 		– Sell
-168
Closed -$26K – 4842
2014
Q1 		$26K Buy
+168
New +$25.5K ﹤0.01% 4612

Other funds holding ACER

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
California Public Employees Retirement System
California Public Employees Retirement System Sacramento, California $162B AUM 25.78% 1-Year Est. Return
SKK
Shepherd Kaplan Krochuk Boston, Massachusetts $119M AUM 8.32% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
MC
Moors & Cabot Boston, Massachusetts $2.34B AUM 30.42% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
GC
Guggenheim Capital Chicago, Illinois $12.9B AUM 27.3% 1-Year Est. Return
PGFC
Peapack-Gladstone Financial Corp Bedminster, New Jersey $7.82B AUM 21.06% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Credit Suisse's ACER Position: Q2 2014 in Review

Credit Suisse sold out of Acer Therapeutics Inc (ACER) in Q2 2014, closing a stake of 168 shares — an estimated $26K sold.

Credit Suisse first reported a position in ACER in Q1 2014 and held it in 1 quarter. The position peaked at $26K in Q1 2014. 16 funds tracked by Wall St. Rank hold ACER as of Q2 2014.

  • Credit Suisse reported no remaining Acer Therapeutics Inc position as of Q2 2014 after selling out during the quarter.
  • Credit Suisse sold 168 Acer Therapeutics Inc shares in Q2 2014, an estimated $26K.
  • Credit Suisse first reported a position in Acer Therapeutics Inc in Q1 2014 and held it in 1 quarter.
  • Credit Suisse's Acer Therapeutics Inc position peaked at $26K in Q1 2014.
  • 16 funds tracked by Wall St. Rank held Acer Therapeutics Inc as of Q2 2014.

Based on Credit Suisse's 13F filing for Q2 2014, filed 11 Aug 2014.